Cardiology & Circulatory System > Nova Content

(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »

LONDON (Reuters) - GlaxoSmithKline Plc has agreed in principle to settle several long-standing disputes with the U.S. government over the way it marketed and... Read More »

On October 31st, the company Medtronic received US Federal Food and Drug Administration approval to treat Narrow Iliac arteries with the use of the Cobalt Chromium... Read More »

  Medtronic Inc has developed a new device  for the treatment of peripheral artery disease. This new FDA approved device, dubbed the Assurant Cobalt... Read More »

CHICAGO (Reuters) - Stimulants used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes or sudden death, U.S... Read More »

  Bristol-Myers Squibb is combining its protease inhibitor Reyataz (atazanavir sulfate) with a pharmacoenhancing agent from Gilead Sciences Inc. called... Read More »

(Reuters) - U.S. device reviewers said a Medtronic Inc device was effective for treating a common heart rhythm disorder, but raised concerns about its safety... Read More »

  By Natasha Baker               TOKYO (Reuters) - Want to reduce stress and improve mental focus? A new app that... Read More »

  (Reuters) - AtriCure Inc's Synergy Ablation System heart-rhythm device is safe and effective, but its trial size and design raise some concerns, U.S... Read More »